Drug Profile
Research programme: anti-HGF monoclonal antibodies - Amgen
Alternative Names: 2.12.1; 2.4.4; Anti-HGF(hu)mAb 2.12.1; Anti-HGF(hu)mAb 2.4.4; Hepatocyte growth factor inhibitors - AmgenLatest Information Update: 30 Mar 2010
Price :
$50
*
At a glance
- Originator Amgen
- Class Monoclonal antibodies
- Mechanism of Action Hepatocyte growth factor inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 11 Sep 2008 Preclinical development is ongoing in the US
- 02 May 2006 Preclinical trials in Cancer in USA (unspecified route)